---
schema_version: "secwatch.filing_event.v1"
accession: "0001722482-24-000084"
form_type: "8-K"
ticker: "AVTR"
cik: "0001722482"
company_name: "Avantor, Inc."
filed_at: "2024-04-05T23:59:59+00:00"
generated_at: "2026-06-04T01:51:37.165257+00:00"
event_type: "debt"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Avantor refinances $772M term loans at lower rate; former EVP to advise

## Summary
- Refinanced $772.4M Incremental B-6 Dollar Term Loans at SOFR + 2.00% (down from +2.25% on prior loans).
- New loans mature Nov 6, 2027, same maturity as refinanced B-5 loans; proceeds used to repay existing B-5 term loans.
- Dr. Gerard Brophy, former EVP Biopharma Production, gets consulting deals: $180K/yr cash + $25K/yr + $50K RSU for SAB chair role through Feb 2027.
- Consulting agreements include noncompetition, nonsolicitation, and IP assignment provisions.

## SEC filing metadata
- accession: 0001722482-24-000084
- form_type: 8-K
- ticker: AVTR
- cik: 0001722482
- company_name: Avantor, Inc.
- filed_at: 2024-04-05T23:59:59+00:00
- event_type: debt
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1722482/000172248224000084/0001722482-24-000084-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1722482/000172248224000084/avtr-20240402.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001722482-24-000084
- JSON: https://secwatch.observer/filing/0001722482-24-000084.json
- Plain text: https://secwatch.observer/filing/0001722482-24-000084.txt

## Key facts
- Debt Financings
  Avantor, Inc. incurred term loan of $772,396,875.00 with Goldman Sachs Bank USA at SOFR plus a spread of 2.00% per annum maturing November 6, 2027.
  - Instrument: term loan
  - Principal: $772,396,875.00
  - Counterparty: Goldman Sachs Bank USA
  - Rate: SOFR plus a spread of 2.00% per annum
  - Maturity: November 6, 2027
  - Event: incurrence
  source text: the Borrower obtained a $772,396,875.00 tranche of senior secured U.S. dollar term loans (the “Incremental B-6 Dollar Term Loans”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1722482/000172248224000084/0001722482-24-000084-index.htm
- Material Agreements
  Avantor, Inc. amended Amendment No. 12 with Goldman Sachs Bank USA, as administrative agent and collateral agent valued at $772,396,875.00 (effective 2024-04-02).
  - Action: amendment
  - Agreement: credit facility
  - Counterparty: Goldman Sachs Bank USA, as administrative agent and collateral agent
  - Value: $772,396,875.00
  - Effective: 2024-04-02
  source text: On April 2, 2024 (the “Effective Date”), Avantor, Inc.’s (the “Company”) wholly owned subsidiary, Avantor Funding, Inc. (the “Borrower”), entered into Amendment No. 12 (the “Credit Agreement Amendment”) to Credit Agreement, dated as of November 21, 2017
  evidence_url: https://www.sec.gov/Archives/edgar/data/1722482/000172248224000084/0001722482-24-000084-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.